1. Home
  2. SGMO vs BANX Comparison

SGMO vs BANX Comparison

Compare SGMO & BANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.40

Market Cap

135.1M

Sector

Health Care

ML Signal

HOLD

Logo ArrowMark Financial Corp.

BANX

ArrowMark Financial Corp.

HOLD

Current Price

$21.21

Market Cap

172.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGMO
BANX
Founded
1995
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
135.1M
172.0M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
SGMO
BANX
Price
$0.40
$21.21
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$5.60
N/A
AVG Volume (30 Days)
4.3M
23.4K
Earning Date
11-06-2025
06-17-2025
Dividend Yield
N/A
9.66%
EPS Growth
N/A
N/A
EPS
N/A
2.35
Revenue
$32,875,000.00
$29,467,794.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$8.88
Revenue Growth
N/A
2.73
52 Week Low
$0.37
$17.99
52 Week High
$1.40
$21.67

Technical Indicators

Market Signals
Indicator
SGMO
BANX
Relative Strength Index (RSI) 41.13 40.24
Support Level $0.37 $21.20
Resistance Level $0.48 $21.79
Average True Range (ATR) 0.03 0.37
MACD -0.00 -0.08
Stochastic Oscillator 30.36 40.99

Price Performance

Historical Comparison
SGMO
BANX

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

About BANX ArrowMark Financial Corp.

ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.

Share on Social Networks: